[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356189-105":59,"doc-detail-356189-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-risk-genes-s1pr5-cmc1-and-asah1-as-potential-targets-for-the-diagnosis-immunotherapy-and-treatment-of-colon-adenocarcinoma-research-article","The Risk Genes S1PR5, CMC1, and ASAH1 as Potential Targets for the Diagnosis, Immunotherapy, and Treatment of Colon Adenocarcinoma - Research Article","","Objective: Develop a new immune cell function (ICF) risk model for colon adenocarcinoma (COAD) using single-cell and bulk RNA-seq to support diagnosis, prognosis prediction, and immunotherapy decision-making. Methods: Immune-related gene sets were assembled from literature and applied to a COAD scRNA-seq dataset (GSE146771), with Lasso-derived gene signatures validated across multiple independent cohorts, assessed via 10-fold testing and a clinical nomogram. Results: A 20-set enrichment screen produced a 10-gene risk profile with stable performance and independent prognostic value. Low-risk patients showed improved immunotherapy benefit, and experiments indicated S1PR5 high with CMC1/ASAH1 low, implicating these genes in CRC proliferation control. Conclusion: The model identifies S1PR5, CMC1, and ASAH1 as potential therapeutic targets and guides treatment stratification in COAD.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-risk-genes-s1pr5-cmc1-and-asah1-as-potential-targets-for-the-diagnosis-immunotherapy-and-treatment-of-colon-adenocarcinoma-research-article/356189/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-risk-genes-s1pr5-cmc1-and-asah1-as-potential-targets-for-the-diagnosis-immunotherapy-and-treatment-of-colon-adenocarcinoma-research-article/356189.png","ImageObject",300,407,{"name":92,"@type":93},"acoobca","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main goal of the study on colon adenocarcinoma?","Question",{"text":113,"@type":114},"To construct and validate a new immune cell function (ICF) risk model using single-cell and bulk RNA sequencing, aiming to improve understanding and clinical applications for colon adenocarcinoma.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were the gene signature and risk model built and validated?",{"text":118,"@type":114},"Immune function gene sets were collected from literature and integrated with a COAD single-cell dataset (GSE146771). A Lasso-based multi-gene signature was derived, then assessed with 10-fold cross-testing, a nomogram for clinical independence, and validation in multiple independent cohorts.",{"name":120,"@type":111,"acceptedAnswer":121},"Which genes were highlighted as key model genes and what did the experiments show?",{"text":122,"@type":114},"S1PR5, CMC1, and ASAH1 were identified as model genes. qPCR and immunohistochemistry showed S1PR5 expression higher in COAD tissues, while CMC1 and ASAH1 were lower, and functional experiments suggested they may regulate CRC cell proliferation capacity.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},356189,1790246323,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},3985747870733,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Send Orders for Reprints [to reprints@benthamscience.net](to reprints@benthamscience.net)  \n3211  \nCurrent Medicinal Chemistry, 2026, 33, 3211-3245  \nRESEARCH ARTICLE  \nThe Risk Genes S1PR5, CMC1, and ASAH1 as Potential Targets for the Diagnosis, Immunotherapy, and Treatment of Colon Adenocarcinoma by Single-Cell and Bulk RNA Sequencing Analysis  \n| \u003Cbr>| 􀀌􀀞\\#\\#4 􀀆9FG􀀄G􀀅􀀅􀀓 􀀞\\#\\#4 8E7E􀀄9DF􀀅 |  |\n| --- | --- | --- |\n|  | 􀀂􀀃􀀄􀀄􀀅􀀆􀀇􀀈􀀅􀀉􀀊􀀋􀀊􀀆􀀌􀀍􀀂􀀎􀀅􀀏􀀊􀀐􀀇􀀄􀀑 |  |\n|  |  | 􀀞 􀀛􀀂􀀖􀀇􀀛􀀋􀀖􀀅􀀇􀀙􀀊􀀖􀀅􀀗􀀔􀀊􀀕􀀋􀀖􀀅􀀗 􀀊􀀋􀀞􀀙􀀃􀀛􀀗! 􀀂􀀖\"\\#􀀛􀀄􀀇\u003Cbr>􀀚􀀛$􀀙􀀛%􀀜􀀙􀀖 &􀀛\\#􀀙􀀆􀀙􀀖􀀅􀀗􀀘 􀀛􀀃􀀙􀀜􀀇􀀋!\u003Cbr>􀀂􀀃􀀄􀀅􀀆􀀇􀀈􀀉􀀊􀀋􀀃􀀄􀀊􀀃 |\n| \u003Cbr>|  |  |\n|  |  |  |\n\nZipeng Xu1,\\#, Jiantao Gong2,\\#, Weidong Hu 1, Chen Ge 1, Genxi Tong 1, Fengjun Cai 1, Zhenghai Zhu 1, Yihang Yuan3,* and Chaobo Chen 1,*  \n1Department of General Surgery, Xishan People’s Hospital of Wuxi City, Wuxi, 214105, China; 2Department of Gastroenterology, Xishan People’s Hospital of Wuxi City, Wuxi, 214105, China; 3Department of General Surgery, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, 210008, China  \n© 2026 The Author(s). Published by Bentham Science Publisher. This is an open access article published under CC BY 4.0 [https://creativecommons.org/licenses/by/4.0/legalcode](https://creativecommons.org/licenses/by/4.0/legalcode)  \n􀀂􀀃􀀄􀀄􀀅􀀆􀀇 􀀉􀀅􀀊􀀋􀀌􀀋􀀆􀀍􀀎 􀀂􀀏􀀅􀀐􀀋􀀑􀀇􀀄􀀒  \nAbstract: Objective: Globally, one of the main causes of cancer-related mortality is Colon Adenocarcinoma (COAD) . In this study, a new special Immune Cell Functions (ICF) risk model was constructed using single-cell and bulk RNA sequencing data to develop a new understanding and clinical applications for COAD.  \nMethods: The immune function gene sets were downloaded from a literature reference, and the COAD single-cell dataset GSE146771 was downloaded from the Tumour Immune Single Cell Hub database. Using Lasso analysis, a multiple gene signature was made from the enrichment scores of immune function gene sets that were enriched in different ways. Robust validation of the signature was then performed in multiple independent cohorts. After that, we built the model using a 10-fold cross-test and evaluated its independence for clinical usage using a nomogram. We also investigated the connection between signature and immune function, genetic variation, immunotherapy, and the cancer immunological microenvironment. Lastly, we used qPCR and immunohistochemistry to examine the expression of the unreported model genes. To find the regulatory functions ofunreported model genes, an EdU assay was employed.  \nResults: First, 20 differentially enriched immune function gene sets were identified. Ten genes can be used as a risk profile to assess the prognosis of colon cancer, according to Lasso regression analysis. Signature performance was stable in both the training cohort and two independent GEO external cohorts, and risk scores were confirmed as independent prognostic factors. At the same time, our risk model continued to be highly predictive across various clinical clusters and clinical characteristics, such as immune checkpoints, tumour genome mutations, and chemotherapeutic drug resistance. Patients in the low-risk group have exhibited a higher chance of benefiting from immunotherapy, according to immunotherapy response research. qPCR and immunohistochemistry analysis have revealed S1PR5 expression as high in COAD tissues, while CMC1 and ASAH1 expression has been found to be low. According to the findings ofthe functional experiment, S1PR5, CMC1, and ASAH1 may control the ability of CRC cells to proliferate.  \nConclusion: In this study, using scRNA-seq and bulk RNA-seq data, we created a risk model to predict the prognosis and effectiveness of immunotherapy in patients with COAD. In addition, we have discovered three model genes (S1PR5, CMC1, and ASAH1) that have not been reported before. These genes have the potential to be novel therapeutic targets in Colorectal Cancer (CRC) . These findings suggest that this model could be used to evaluate th","cbCaisBprxF4V8CG","https://ap.wps.com/l/cbCaisBprxF4V8CG","pdf",20277974,35,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Colorectal cancer burden and metastasis\n## Advances in targeted therapy, immunotherapy, and precision medicine","[{\"question\":\"What is the main goal of the study on colon adenocarcinoma?\",\"answer\":\"To construct and validate a new immune cell function (ICF) risk model using single-cell and bulk RNA sequencing, aiming to improve understanding and clinical applications for colon adenocarcinoma.\"},{\"question\":\"How were the gene signature and risk model built and validated?\",\"answer\":\"Immune function gene sets were collected from literature and integrated with a COAD single-cell dataset (GSE146771). A Lasso-based multi-gene signature was derived, then assessed with 10-fold cross-testing, a nomogram for clinical independence, and validation in multiple independent cohorts.\"},{\"question\":\"Which genes were highlighted as key model genes and what did the experiments show?\",\"answer\":\"S1PR5, CMC1, and ASAH1 were identified as model genes. qPCR and immunohistochemistry showed S1PR5 expression higher in COAD tissues, while CMC1 and ASAH1 were lower, and functional experiments suggested they may regulate CRC cell proliferation capacity.\"}]","The Risk Genes S1PR5, CMC1, and ASAH1 as Potential Targets for the Diagnosis, Immunotherapy, and Treatment of Colon Adenocarcinoma - Research Article | PDF",1790123945,88,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be21f79e6dc5afecfb3992e98cbeee5e.webp",983,1272,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be21ccfb47a16a31061ee293587c8b67.webp",982,1270,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/49eb6744b72050a3aeaa64a99b8fbae1.webp",981,1269,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f4449d5d365a52bc5c5ae82207019a96.webp",980,1268]